We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics

News   Nov 24, 2016

 
Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
 
 
Advertisement
 

RELATED ARTICLES

Gene Therapy for Children Born Without an Immune System

News

An investigational gene therapy can safely restore the immune systems of infants and children who have a rare, life-threatening inherited immunodeficiency disorder, according to research supported in part by the National Institutes of Health.

READ MORE

Second Possible Effective Mechanism of Remdesivir Discovered

News

SARS-CoV-2 suppresses host cell defense mechanisms using the virus protein nsP3. Using structural analyses, researchers have discovered that a decomposition product of the virostatic agent remdesivir binds to nsP3.

READ MORE

Damage to White Matter Linked to Worse Post-Brain Injury Outcomes

News

A new study challenges the idea that gray matter is more important than white matter when it comes to cognitive health and function. The findings may help neurologists better predict the long-term effects of strokes and other forms of traumatic brain injury.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE